Organogenesis Holdings Financial Report Expected Soon
Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the regenerative medicine arena, is poised to unveil its third-quarter financial results for the fiscal year 2024. This highly anticipated announcement is set to take place after the market closes on a Tuesday in mid-November.
Conference Call and Details
The management of Organogenesis will host a live conference call to discuss the financial results comprehensively. This session is scheduled for 5:00 p.m. Eastern Time on the same day as the financial release. During the call, the leadership will share insights into the company’s performance and any pertinent updates regarding future strategies.
How to Access the Call
Participants interested in joining the call can do so through a live webcast. Additionally, there is an option to join via teleconference. The company's official website will house the archived version of the call, ensuring that attendees can revisit the discussions for up to one year.
Insights into Organogenesis Holdings
Organogenesis Holdings Inc. stands at the forefront of regenerative medicine, with a focus on developing and commercializing solutions tailored for advanced wound care, as well as surgical and sports medicine markets. The company boasts a diverse range of innovative products designed to cater to patient needs across various stages of care.
Commitment to Innovation
The leadership at Organogenesis emphasizes their dedication to advancing patient care through cutting-edge regenerative technologies. This commitment not only enhances patient outcomes but also solidifies the company's reputation within the medical community.
Investor Relations and Contact Information
For investors seeking more detailed information or wishing to engage with the company, Mike Piccinino, CFA from ICR Westwicke is available for inquiries. Investors can reach him via email at OrganoIR@westwicke.com.
Media Inquiries
For press-related questions, Organogenesis can be contacted through their communications team at communications@organo.com. This channel ensures that media representatives receive timely and relevant information pertaining to the company's developments.
Frequently Asked Questions
When will Organogenesis announce its Q3 2024 financial results?
The announcement is scheduled for a Tuesday in mid-November, after market close.
How can I participate in the conference call?
You can participate via the live webcast or teleconference available on the company’s website.
Who can I contact for investor inquiries?
For investor inquiries, contact Mike Piccinino, CFA at ICR Westwicke through OrganoIR@westwicke.com.
What markets does Organogenesis focus on?
Organogenesis concentrates on advanced wound care, surgical, and sports medicine markets with its regenerative products.
Where can I find archived webcasts of the calls?
The archived webcasts will be available on the company website for approximately one year.